This study examined the efficacy and safety of osmotic release oral system methylphenidate
(OROS MPH) as compared with immediate-release MPH (IR MPH) in children with attention …

Objectives: The purpose of this study was to identify the optimal dose of osmotic release oral
system methylphenidate (OROS-MPH) using a dosage forced-titration scheme to achieve …

Objective: The purpose of this study was to compare the short-term efficacy, tolerability, and
1-year adherence in Chinese children and adolescents with attention-deficit/hyperactivity …

Aims: To determine factors for switching to osmotic release oral system methylphenidate
(OROS‐MPH) among poor adherents to immediate‐release methylphenidate (IR‐MPH); and …

OBJECTIVE: To evaluate the efficacy and safety of osmotic-release methylphenidate (OROS-
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …

Background Psychostimulants remain first-line treatment options for the management of
attention-deficit/hyperactivity disorder (ADHD). A multilayer extended-release bead …

Background: Children and adolescents are being treated increasingly for attention-
deficit/hyperactivity disorder (ADHD) with a variety of stimulants in higher than Food and …

Background Despite the persistence of attention-deficit/hyperactivity disorder (ADHD) into
adolescence, little is known about the efficacy and tolerability of stimulant medications in this …

Objective: This phase 3, laboratory classroom study assessed the efficacy and safety of
methylphenidate hydrochloride extended-release chewable tablets (MPH ERCT) compared …

Background: Attention-deficit hyperactivity disorder (ADHD) is the most common mental and
behavioral disorder in school-aged children. This study evaluated the effect of osmotic …